Previous studies found that RIP3-dependent necroptosis was activated in SLE patients and inhibition of RIP3 kinase could inhibit the development of LN in MRL/lpr mice [46, 47]. The gene discussed is RIPK3; the disease is systemic lupus erythematosus.